REGENERON PHARMACEUTICALS, INC. Accounts Payable, Trade, Current
REGENERON PHARMACEUTICALS, INC. (REGN) had Accounts Payable, Trade, Current of $178.18 million as of 2017-12-31, per its 10-K filed 2018-02-08.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableTradeCurrent · last filed 2018-02-08
- 2017-12-31: Accounts Payable, Trade, Current $178.18M.
- 2017-09-30: Accounts Payable, Trade, Current $153.95M.
- 2017-06-30: Accounts Payable, Trade, Current $151.37M.
- 2017-03-31: Accounts Payable, Trade, Current $141.80M.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2017-12-31 | $178.18M 10-K · filed 2018-02-08 |
| 2017-09-30 | $153.95M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $151.37M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $141.80M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $134.98M 10-K · filed 2018-02-08 |
| 2016-09-30 | $124.50M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $101.72M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $120.59M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $140.96M 10-K · filed 2017-02-09 |
| 2015-09-30 | $106.92M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $130.02M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $90.60M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $99.51M 10-K · filed 2016-02-11 |
| 2014-09-30 | $47.34M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $47.23M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $32.69M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $61.94M 10-K · filed 2015-02-12 |
| 2013-09-30 | $31.19M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $24.42M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $24.73M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $38.93M 10-K · filed 2014-02-13 |
| 2012-09-30 | $21.94M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $25.67M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $25.39M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $27.74M 10-K · filed 2013-02-15 |
| 2011-09-30 | $17.31M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $25.95M 10-Q · filed 2011-07-28 |
| 2010-12-31 | $15.59M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |